Search for: "SANDOZ, INC."
Results 541 - 560
of 679
Sorted by Relevance
|
Sort by Date
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
7 Jul 2009, 5:12 am
” Id., at 7135-36 (citing Sandoz v. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
11 Jan 2022, 11:45 am
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
11 Jan 2022, 11:45 am
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
27 Aug 2012, 9:31 am
Sandoz, Inc., 678 F.3d 1280, 1290 (Fed. [read post]
22 Dec 2010, 10:18 am
Sandoz, Inc., 544 F.3d 1341, 1354 (Fed. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
27 Aug 2012, 9:31 am
Sandoz, Inc., 678 F.3d 1280, 1290 (Fed. [read post]
1 Feb 2013, 9:42 am
Sandoz Inc., 2013 WL 308768 (S.D. [read post]
15 Jan 2008, 3:06 am
Sandoz, Inc. et al filed 03/28/07 1:07-cv-01763 Minemyer v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
5 Apr 2007, 5:39 am
Sandoz Pharmaceuticals Corp., 172 F. [read post]
5 Jul 2007, 10:37 am
Squibb & Sons, Inc., 682 P.2d 832, 835 (Utah 1984).Virginia: Pfizer, Inc. v. [read post]
25 Nov 2009, 3:00 am
(IP finance) Australia Trade mark use: We need a more balanced solution – FCA decision in Alcon v Bausch & Lomb (Australian Trade Marks Law Blog) FCA on trade marks as security for costs: Austin, Nichols & Co Inc v Lodestar Anstalt (ipwars) Minister for Innovation decides not to change regulatory regime for books – publishers keep territorial exclusivity (LawFont) (Managing Intellectual Property) Non-English language publications may not be citable art: APO… [read post]
12 Jan 2017, 7:01 am
Sandoz Inc., 15-1195), and cases involving trial before nonlawyer judges (Davis v. [read post]
